nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemfibrozil—Bupranolol—Salbutamol—chronic obstructive pulmonary disease	0.366	1	CrCrCtD
Gemfibrozil—CYP1A2—chronic obstructive pulmonary disease	0.259	1	CbGaD
Gemfibrozil—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0301	0.115	CbGbCtD
Gemfibrozil—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0301	0.115	CbGbCtD
Gemfibrozil—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0272	0.104	CbGbCtD
Gemfibrozil—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.025	0.0959	CbGbCtD
Gemfibrozil—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.025	0.0959	CbGbCtD
Gemfibrozil—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0236	0.0905	CbGbCtD
Gemfibrozil—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0192	0.0736	CbGbCtD
Gemfibrozil—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.019	0.0727	CbGbCtD
Gemfibrozil—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.013	0.0497	CbGbCtD
Gemfibrozil—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0126	0.0485	CbGbCtD
Gemfibrozil—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0124	0.0474	CbGbCtD
Gemfibrozil—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.011	0.0423	CbGbCtD
Gemfibrozil—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00647	0.0248	CbGbCtD
Gemfibrozil—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00611	0.0234	CbGbCtD
Gemfibrozil—Bupranolol—ADRB2—chronic obstructive pulmonary disease	0.00152	1	CrCbGaD
Gemfibrozil—Shock—Aminophylline—chronic obstructive pulmonary disease	0.000243	0.00317	CcSEcCtD
Gemfibrozil—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.000243	0.00317	CcSEcCtD
Gemfibrozil—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.000243	0.00317	CcSEcCtD
Gemfibrozil—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.000243	0.00317	CcSEcCtD
Gemfibrozil—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000242	0.00316	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.000241	0.00315	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000238	0.00311	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000238	0.00311	CcSEcCtD
Gemfibrozil—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000235	0.00307	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000233	0.00305	CcSEcCtD
Gemfibrozil—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000233	0.00305	CcSEcCtD
Gemfibrozil—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000233	0.00304	CcSEcCtD
Gemfibrozil—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000233	0.00304	CcSEcCtD
Gemfibrozil—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000232	0.00303	CcSEcCtD
Gemfibrozil—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.000232	0.00302	CcSEcCtD
Gemfibrozil—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.000232	0.00302	CcSEcCtD
Gemfibrozil—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000229	0.00299	CcSEcCtD
Gemfibrozil—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000228	0.00298	CcSEcCtD
Gemfibrozil—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.000227	0.00296	CcSEcCtD
Gemfibrozil—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000226	0.00295	CcSEcCtD
Gemfibrozil—Tension—Formoterol—chronic obstructive pulmonary disease	0.000226	0.00295	CcSEcCtD
Gemfibrozil—Tension—Arformoterol—chronic obstructive pulmonary disease	0.000226	0.00295	CcSEcCtD
Gemfibrozil—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.000225	0.00294	CcSEcCtD
Gemfibrozil—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.000225	0.00294	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000225	0.00294	CcSEcCtD
Gemfibrozil—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000224	0.00292	CcSEcCtD
Gemfibrozil—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000224	0.00292	CcSEcCtD
Gemfibrozil—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00022	0.00287	CcSEcCtD
Gemfibrozil—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000219	0.00286	CcSEcCtD
Gemfibrozil—Cataract—Prednisone—chronic obstructive pulmonary disease	0.000218	0.00284	CcSEcCtD
Gemfibrozil—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000217	0.00284	CcSEcCtD
Gemfibrozil—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.000214	0.0028	CcSEcCtD
Gemfibrozil—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000213	0.00278	CcSEcCtD
Gemfibrozil—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000213	0.00278	CcSEcCtD
Gemfibrozil—Vasculitis—Prednisone—chronic obstructive pulmonary disease	0.000212	0.00277	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000212	0.00277	CcSEcCtD
Gemfibrozil—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000211	0.00276	CcSEcCtD
Gemfibrozil—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.00021	0.00275	CcSEcCtD
Gemfibrozil—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.00021	0.00275	CcSEcCtD
Gemfibrozil—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000209	0.00273	CcSEcCtD
Gemfibrozil—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000206	0.00269	CcSEcCtD
Gemfibrozil—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000205	0.00268	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000202	0.00264	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000201	0.00262	CcSEcCtD
Gemfibrozil—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000201	0.00262	CcSEcCtD
Gemfibrozil—Cough—Formoterol—chronic obstructive pulmonary disease	0.000201	0.00262	CcSEcCtD
Gemfibrozil—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000199	0.0026	CcSEcCtD
Gemfibrozil—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000199	0.00259	CcSEcCtD
Gemfibrozil—Cough—Montelukast—chronic obstructive pulmonary disease	0.000197	0.00257	CcSEcCtD
Gemfibrozil—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000196	0.00256	CcSEcCtD
Gemfibrozil—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000196	0.00256	CcSEcCtD
Gemfibrozil—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000196	0.00256	CcSEcCtD
Gemfibrozil—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000196	0.00256	CcSEcCtD
Gemfibrozil—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000196	0.00256	CcSEcCtD
Gemfibrozil—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000196	0.00256	CcSEcCtD
Gemfibrozil—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000196	0.00256	CcSEcCtD
Gemfibrozil—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000195	0.00255	CcSEcCtD
Gemfibrozil—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000195	0.00255	CcSEcCtD
Gemfibrozil—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000195	0.00255	CcSEcCtD
Gemfibrozil—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000195	0.00254	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000195	0.00254	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000195	0.00254	CcSEcCtD
Gemfibrozil—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000192	0.00251	CcSEcCtD
Gemfibrozil—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000192	0.00251	CcSEcCtD
Gemfibrozil—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000191	0.00249	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000191	0.00249	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00019	0.00249	CcSEcCtD
Gemfibrozil—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00019	0.00248	CcSEcCtD
Gemfibrozil—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000188	0.00245	CcSEcCtD
Gemfibrozil—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000188	0.00245	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000188	0.00245	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000188	0.00245	CcSEcCtD
Gemfibrozil—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000185	0.00242	CcSEcCtD
Gemfibrozil—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000185	0.00242	CcSEcCtD
Gemfibrozil—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000185	0.00242	CcSEcCtD
Gemfibrozil—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000185	0.00241	CcSEcCtD
Gemfibrozil—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000184	0.00241	CcSEcCtD
Gemfibrozil—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000184	0.00241	CcSEcCtD
Gemfibrozil—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000184	0.0024	CcSEcCtD
Gemfibrozil—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000184	0.0024	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000184	0.0024	CcSEcCtD
Gemfibrozil—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000183	0.00238	CcSEcCtD
Gemfibrozil—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000182	0.00238	CcSEcCtD
Gemfibrozil—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000182	0.00238	CcSEcCtD
Gemfibrozil—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00018	0.00236	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00018	0.00235	CcSEcCtD
Gemfibrozil—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000179	0.00233	CcSEcCtD
Gemfibrozil—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000177	0.00232	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000177	0.00232	CcSEcCtD
Gemfibrozil—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000175	0.00229	CcSEcCtD
Gemfibrozil—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000175	0.00228	CcSEcCtD
Gemfibrozil—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000175	0.00228	CcSEcCtD
Gemfibrozil—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000174	0.00227	CcSEcCtD
Gemfibrozil—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000172	0.00225	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000171	0.00223	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000171	0.00223	CcSEcCtD
Gemfibrozil—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000169	0.0022	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000168	0.00219	CcSEcCtD
Gemfibrozil—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000167	0.00218	CcSEcCtD
Gemfibrozil—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000167	0.00218	CcSEcCtD
Gemfibrozil—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000165	0.00216	CcSEcCtD
Gemfibrozil—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000165	0.00216	CcSEcCtD
Gemfibrozil—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000165	0.00216	CcSEcCtD
Gemfibrozil—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000165	0.00215	CcSEcCtD
Gemfibrozil—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000164	0.00214	CcSEcCtD
Gemfibrozil—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000163	0.00213	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000162	0.00212	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000162	0.00212	CcSEcCtD
Gemfibrozil—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000162	0.00211	CcSEcCtD
Gemfibrozil—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000162	0.00211	CcSEcCtD
Gemfibrozil—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000162	0.00211	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000162	0.00211	CcSEcCtD
Gemfibrozil—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000161	0.0021	CcSEcCtD
Gemfibrozil—Pain—Formoterol—chronic obstructive pulmonary disease	0.000161	0.0021	CcSEcCtD
Gemfibrozil—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000161	0.0021	CcSEcCtD
Gemfibrozil—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000161	0.0021	CcSEcCtD
Gemfibrozil—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000159	0.00208	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000159	0.00207	CcSEcCtD
Gemfibrozil—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000159	0.00207	CcSEcCtD
Gemfibrozil—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000158	0.00206	CcSEcCtD
Gemfibrozil—Pain—Montelukast—chronic obstructive pulmonary disease	0.000157	0.00205	CcSEcCtD
Gemfibrozil—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000157	0.00205	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000156	0.00204	CcSEcCtD
Gemfibrozil—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000156	0.00204	CcSEcCtD
Gemfibrozil—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000156	0.00203	CcSEcCtD
Gemfibrozil—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000155	0.00203	CcSEcCtD
Gemfibrozil—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000155	0.00202	CcSEcCtD
Gemfibrozil—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000155	0.00202	CcSEcCtD
Gemfibrozil—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000155	0.00202	CcSEcCtD
Gemfibrozil—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000154	0.00201	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000154	0.00201	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000154	0.00201	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000153	0.002	CcSEcCtD
Gemfibrozil—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000153	0.002	CcSEcCtD
Gemfibrozil—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.00198	CcSEcCtD
Gemfibrozil—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.00198	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00015	0.00196	CcSEcCtD
Gemfibrozil—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000149	0.00195	CcSEcCtD
Gemfibrozil—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000149	0.00195	CcSEcCtD
Gemfibrozil—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000149	0.00194	CcSEcCtD
Gemfibrozil—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000149	0.00194	CcSEcCtD
Gemfibrozil—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000148	0.00193	CcSEcCtD
Gemfibrozil—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000147	0.00192	CcSEcCtD
Gemfibrozil—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000147	0.00191	CcSEcCtD
Gemfibrozil—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000147	0.00191	CcSEcCtD
Gemfibrozil—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000146	0.00191	CcSEcCtD
Gemfibrozil—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.00191	CcSEcCtD
Gemfibrozil—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000146	0.0019	CcSEcCtD
Gemfibrozil—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000145	0.0019	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000145	0.00189	CcSEcCtD
Gemfibrozil—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000141	0.00184	CcSEcCtD
Gemfibrozil—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00014	0.00183	CcSEcCtD
Gemfibrozil—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000138	0.00181	CcSEcCtD
Gemfibrozil—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000135	0.00176	CcSEcCtD
Gemfibrozil—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000135	0.00176	CcSEcCtD
Gemfibrozil—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000133	0.00174	CcSEcCtD
Gemfibrozil—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000133	0.00174	CcSEcCtD
Gemfibrozil—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000133	0.00173	CcSEcCtD
Gemfibrozil—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000132	0.00172	CcSEcCtD
Gemfibrozil—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00013	0.0017	CcSEcCtD
Gemfibrozil—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000129	0.00168	CcSEcCtD
Gemfibrozil—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000129	0.00168	CcSEcCtD
Gemfibrozil—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000127	0.00166	CcSEcCtD
Gemfibrozil—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000127	0.00166	CcSEcCtD
Gemfibrozil—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000126	0.00164	CcSEcCtD
Gemfibrozil—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000125	0.00164	CcSEcCtD
Gemfibrozil—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000124	0.00162	CcSEcCtD
Gemfibrozil—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000124	0.00162	CcSEcCtD
Gemfibrozil—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000122	0.00159	CcSEcCtD
Gemfibrozil—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000121	0.00158	CcSEcCtD
Gemfibrozil—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.00012	0.00156	CcSEcCtD
Gemfibrozil—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000119	0.00156	CcSEcCtD
Gemfibrozil—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000119	0.00156	CcSEcCtD
Gemfibrozil—Rash—Formoterol—chronic obstructive pulmonary disease	0.000118	0.00155	CcSEcCtD
Gemfibrozil—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000118	0.00155	CcSEcCtD
Gemfibrozil—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000118	0.00155	CcSEcCtD
Gemfibrozil—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000118	0.00155	CcSEcCtD
Gemfibrozil—Headache—Formoterol—chronic obstructive pulmonary disease	0.000118	0.00154	CcSEcCtD
Gemfibrozil—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000118	0.00154	CcSEcCtD
Gemfibrozil—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000118	0.00154	CcSEcCtD
Gemfibrozil—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000117	0.00153	CcSEcCtD
Gemfibrozil—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000117	0.00153	CcSEcCtD
Gemfibrozil—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000117	0.00153	CcSEcCtD
Gemfibrozil—Rash—Montelukast—chronic obstructive pulmonary disease	0.000116	0.00151	CcSEcCtD
Gemfibrozil—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000116	0.00151	CcSEcCtD
Gemfibrozil—Depression—Prednisone—chronic obstructive pulmonary disease	0.000116	0.00151	CcSEcCtD
Gemfibrozil—Headache—Montelukast—chronic obstructive pulmonary disease	0.000115	0.0015	CcSEcCtD
Gemfibrozil—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000114	0.00149	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000114	0.00148	CcSEcCtD
Gemfibrozil—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000113	0.00147	CcSEcCtD
Gemfibrozil—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000112	0.00146	CcSEcCtD
Gemfibrozil—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000112	0.00146	CcSEcCtD
Gemfibrozil—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000112	0.00146	CcSEcCtD
Gemfibrozil—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000112	0.00146	CcSEcCtD
Gemfibrozil—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000112	0.00146	CcSEcCtD
Gemfibrozil—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000112	0.00146	CcSEcCtD
Gemfibrozil—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000111	0.00145	CcSEcCtD
Gemfibrozil—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.00011	0.00143	CcSEcCtD
Gemfibrozil—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000109	0.00143	CcSEcCtD
Gemfibrozil—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000108	0.00141	CcSEcCtD
Gemfibrozil—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000105	0.00138	CcSEcCtD
Gemfibrozil—CYP2C19—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000104	0.00294	CbGpPWpGaD
Gemfibrozil—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000102	0.00134	CcSEcCtD
Gemfibrozil—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000102	0.00133	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000102	0.00133	CcSEcCtD
Gemfibrozil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.0001	0.00282	CbGpPWpGaD
Gemfibrozil—Shock—Prednisolone—chronic obstructive pulmonary disease	0.0001	0.00131	CcSEcCtD
Gemfibrozil—CYP2C8—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	9.96e-05	0.0028	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	9.86e-05	0.00278	CbGpPWpGaD
Gemfibrozil—PPARA—Adipogenesis—SERPINE1—chronic obstructive pulmonary disease	9.74e-05	0.00274	CbGpPWpGaD
Gemfibrozil—Eye disorder—Prednisone—chronic obstructive pulmonary disease	9.72e-05	0.00127	CcSEcCtD
Gemfibrozil—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	9.64e-05	0.00271	CbGpPWpGaD
Gemfibrozil—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	9.61e-05	0.0027	CbGpPWpGaD
Gemfibrozil—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	9.52e-05	0.00268	CbGpPWpGaD
Gemfibrozil—PPARA—Transcriptional regulation of white adipocyte differentiation—TGFB1—chronic obstructive pulmonary disease	9.35e-05	0.00263	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—APIP—chronic obstructive pulmonary disease	9.2e-05	0.00259	CbGpPWpGaD
Gemfibrozil—Alopecia—Prednisone—chronic obstructive pulmonary disease	9.2e-05	0.0012	CcSEcCtD
Gemfibrozil—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	9.14e-05	0.00119	CcSEcCtD
Gemfibrozil—Mental disorder—Prednisone—chronic obstructive pulmonary disease	9.12e-05	0.00119	CcSEcCtD
Gemfibrozil—CYP2C19—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	8.89e-05	0.0025	CbGpPWpGaD
Gemfibrozil—PPARA—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	8.76e-05	0.00247	CbGpPWpGaD
Gemfibrozil—PPARA—Transcriptional regulation of white adipocyte differentiation—TNF—chronic obstructive pulmonary disease	8.73e-05	0.00246	CbGpPWpGaD
Gemfibrozil—Pain—Prednisolone—chronic obstructive pulmonary disease	8.7e-05	0.00114	CcSEcCtD
Gemfibrozil—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	8.61e-05	0.00242	CbGpPWpGaD
Gemfibrozil—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	8.57e-05	0.00241	CbGpPWpGaD
Gemfibrozil—Vision blurred—Prednisone—chronic obstructive pulmonary disease	8.54e-05	0.00111	CcSEcCtD
Gemfibrozil—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	8.5e-05	0.00239	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	8.43e-05	0.00237	CbGpPWpGaD
Gemfibrozil—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	8.38e-05	0.00109	CcSEcCtD
Gemfibrozil—Anaemia—Prednisone—chronic obstructive pulmonary disease	8.37e-05	0.00109	CcSEcCtD
Gemfibrozil—Angioedema—Prednisone—chronic obstructive pulmonary disease	8.28e-05	0.00108	CcSEcCtD
Gemfibrozil—PPARA—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	8.16e-05	0.0023	CbGpPWpGaD
Gemfibrozil—Vertigo—Prednisone—chronic obstructive pulmonary disease	8.14e-05	0.00106	CcSEcCtD
Gemfibrozil—Syncope—Prednisone—chronic obstructive pulmonary disease	8.12e-05	0.00106	CcSEcCtD
Gemfibrozil—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	8.11e-05	0.00228	CbGpPWpGaD
Gemfibrozil—Urticaria—Prednisolone—chronic obstructive pulmonary disease	8.08e-05	0.00106	CcSEcCtD
Gemfibrozil—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	7.96e-05	0.00104	CcSEcCtD
Gemfibrozil—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	7.87e-05	0.00221	CbGpPWpGaD
Gemfibrozil—Convulsion—Prednisone—chronic obstructive pulmonary disease	7.85e-05	0.00102	CcSEcCtD
Gemfibrozil—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	7.82e-05	0.0022	CbGpPWpGaD
Gemfibrozil—PPARA—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	7.8e-05	0.0022	CbGpPWpGaD
Gemfibrozil—Arthralgia—Prednisone—chronic obstructive pulmonary disease	7.71e-05	0.00101	CcSEcCtD
Gemfibrozil—Myalgia—Prednisone—chronic obstructive pulmonary disease	7.71e-05	0.00101	CcSEcCtD
Gemfibrozil—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	7.68e-05	0.00216	CbGpPWpGaD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	7.66e-05	0.001	CcSEcCtD
Gemfibrozil—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	7.58e-05	0.00213	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	7.51e-05	0.00211	CbGpPWpGaD
Gemfibrozil—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	7.41e-05	0.00208	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	7.41e-05	0.00208	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	7.41e-05	0.00208	CbGpPWpGaD
Gemfibrozil—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	7.39e-05	0.000965	CcSEcCtD
Gemfibrozil—Oedema—Prednisone—chronic obstructive pulmonary disease	7.39e-05	0.000965	CcSEcCtD
Gemfibrozil—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	7.3e-05	0.00205	CbGpPWpGaD
Gemfibrozil—Shock—Prednisone—chronic obstructive pulmonary disease	7.27e-05	0.00095	CcSEcCtD
Gemfibrozil—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	7.25e-05	0.000947	CcSEcCtD
Gemfibrozil—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	7.21e-05	0.00203	CbGpPWpGaD
Gemfibrozil—Skin disorder—Prednisone—chronic obstructive pulmonary disease	7.18e-05	0.000938	CcSEcCtD
Gemfibrozil—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	7.01e-05	0.00197	CbGpPWpGaD
Gemfibrozil—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.98e-05	0.00196	CbGpPWpGaD
Gemfibrozil—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	6.93e-05	0.00195	CbGpPWpGaD
Gemfibrozil—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	6.91e-05	0.00195	CbGpPWpGaD
Gemfibrozil—PPARA—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	6.87e-05	0.00193	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	6.87e-05	0.00193	CbGpPWpGaD
Gemfibrozil—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	6.74e-05	0.000879	CcSEcCtD
Gemfibrozil—Dizziness—Prednisolone—chronic obstructive pulmonary disease	6.73e-05	0.000878	CcSEcCtD
Gemfibrozil—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	6.64e-05	0.000867	CcSEcCtD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	6.56e-05	0.00185	CbGpPWpGaD
Gemfibrozil—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	6.51e-05	0.00085	CcSEcCtD
Gemfibrozil—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	6.5e-05	0.00183	CbGpPWpGaD
Gemfibrozil—Rash—Prednisolone—chronic obstructive pulmonary disease	6.41e-05	0.000838	CcSEcCtD
Gemfibrozil—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	6.41e-05	0.000837	CcSEcCtD
Gemfibrozil—Fatigue—Prednisone—chronic obstructive pulmonary disease	6.37e-05	0.000832	CcSEcCtD
Gemfibrozil—Headache—Prednisolone—chronic obstructive pulmonary disease	6.37e-05	0.000832	CcSEcCtD
Gemfibrozil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	6.36e-05	0.00179	CbGpPWpGaD
Gemfibrozil—Constipation—Prednisone—chronic obstructive pulmonary disease	6.32e-05	0.000825	CcSEcCtD
Gemfibrozil—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	6.28e-05	0.00177	CbGpPWpGaD
Gemfibrozil—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.23e-05	0.00175	CbGpPWpGaD
Gemfibrozil—PPARA—Adipogenesis—TGFB1—chronic obstructive pulmonary disease	6.15e-05	0.00173	CbGpPWpGaD
Gemfibrozil—CYP2C8—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.14e-05	0.00173	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.09e-05	0.00172	CbGpPWpGaD
Gemfibrozil—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	6.09e-05	0.000795	CcSEcCtD
Gemfibrozil—CYP2C8—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.07e-05	0.00171	CbGpPWpGaD
Gemfibrozil—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	6.05e-05	0.000789	CcSEcCtD
Gemfibrozil—Nausea—Prednisolone—chronic obstructive pulmonary disease	6.04e-05	0.000789	CcSEcCtD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	6.04e-05	0.0017	CbGpPWpGaD
Gemfibrozil—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	5.99e-05	0.00169	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—GC—chronic obstructive pulmonary disease	5.93e-05	0.00167	CbGpPWpGaD
Gemfibrozil—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	5.91e-05	0.00166	CbGpPWpGaD
Gemfibrozil—Urticaria—Prednisone—chronic obstructive pulmonary disease	5.87e-05	0.000767	CcSEcCtD
Gemfibrozil—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	5.84e-05	0.000763	CcSEcCtD
Gemfibrozil—PPARA—Adipogenesis—TNF—chronic obstructive pulmonary disease	5.74e-05	0.00162	CbGpPWpGaD
Gemfibrozil—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	5.72e-05	0.00161	CbGpPWpGaD
Gemfibrozil—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	5.68e-05	0.0016	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.51e-05	0.00155	CbGpPWpGaD
Gemfibrozil—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.48e-05	0.00154	CbGpPWpGaD
Gemfibrozil—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.42e-05	0.00152	CbGpPWpGaD
Gemfibrozil—Asthenia—Prednisone—chronic obstructive pulmonary disease	5.3e-05	0.000693	CcSEcCtD
Gemfibrozil—Pruritus—Prednisone—chronic obstructive pulmonary disease	5.23e-05	0.000683	CcSEcCtD
Gemfibrozil—SLCO1B1—Metabolism—APIP—chronic obstructive pulmonary disease	5.19e-05	0.00146	CbGpPWpGaD
Gemfibrozil—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	5.16e-05	0.00145	CbGpPWpGaD
Gemfibrozil—CYP2C8—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.1e-05	0.00144	CbGpPWpGaD
Gemfibrozil—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	5.06e-05	0.00142	CbGpPWpGaD
Gemfibrozil—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	5.06e-05	0.00066	CcSEcCtD
Gemfibrozil—CYP2C8—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.03e-05	0.00142	CbGpPWpGaD
Gemfibrozil—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5e-05	0.00141	CbGpPWpGaD
Gemfibrozil—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.94e-05	0.00139	CbGpPWpGaD
Gemfibrozil—Dizziness—Prednisone—chronic obstructive pulmonary disease	4.89e-05	0.000638	CcSEcCtD
Gemfibrozil—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	4.85e-05	0.00137	CbGpPWpGaD
Gemfibrozil—PPARA—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.73e-05	0.00133	CbGpPWpGaD
Gemfibrozil—Vomiting—Prednisone—chronic obstructive pulmonary disease	4.7e-05	0.000614	CcSEcCtD
Gemfibrozil—Rash—Prednisone—chronic obstructive pulmonary disease	4.66e-05	0.000609	CcSEcCtD
Gemfibrozil—Dermatitis—Prednisone—chronic obstructive pulmonary disease	4.66e-05	0.000608	CcSEcCtD
Gemfibrozil—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	4.65e-05	0.00131	CbGpPWpGaD
Gemfibrozil—PPARA—Adipogenesis—IL6—chronic obstructive pulmonary disease	4.63e-05	0.0013	CbGpPWpGaD
Gemfibrozil—Headache—Prednisone—chronic obstructive pulmonary disease	4.63e-05	0.000605	CcSEcCtD
Gemfibrozil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	4.62e-05	0.0013	CbGpPWpGaD
Gemfibrozil—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	4.56e-05	0.00128	CbGpPWpGaD
Gemfibrozil—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.55e-05	0.00128	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.49e-05	0.00126	CbGpPWpGaD
Gemfibrozil—Nausea—Prednisone—chronic obstructive pulmonary disease	4.39e-05	0.000573	CcSEcCtD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.39e-05	0.00124	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.32e-05	0.00121	CbGpPWpGaD
Gemfibrozil—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	4.27e-05	0.0012	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—LEP—chronic obstructive pulmonary disease	4.27e-05	0.0012	CbGpPWpGaD
Gemfibrozil—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.26e-05	0.0012	CbGpPWpGaD
Gemfibrozil—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.22e-05	0.00119	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.2e-05	0.00118	CbGpPWpGaD
Gemfibrozil—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.15e-05	0.00117	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	4.1e-05	0.00115	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.1e-05	0.00115	CbGpPWpGaD
Gemfibrozil—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.91e-05	0.0011	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.86e-05	0.00109	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.85e-05	0.00108	CbGpPWpGaD
Gemfibrozil—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.8e-05	0.00107	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—CTGF—chronic obstructive pulmonary disease	3.76e-05	0.00106	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.75e-05	0.00105	CbGpPWpGaD
Gemfibrozil—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	3.75e-05	0.00105	CbGpPWpGaD
Gemfibrozil—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.71e-05	0.00104	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.7e-05	0.00104	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.66e-05	0.00103	CbGpPWpGaD
Gemfibrozil—PPARA—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	3.57e-05	0.00101	CbGpPWpGaD
Gemfibrozil—PPARA—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	3.56e-05	0.001	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.51e-05	0.000989	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—HDAC2—chronic obstructive pulmonary disease	3.5e-05	0.000985	CbGpPWpGaD
Gemfibrozil—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.49e-05	0.000983	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	3.47e-05	0.000977	CbGpPWpGaD
Gemfibrozil—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.46e-05	0.000975	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.44e-05	0.000969	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.44e-05	0.000968	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.42e-05	0.000962	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.41e-05	0.00096	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—GC—chronic obstructive pulmonary disease	3.34e-05	0.000942	CbGpPWpGaD
Gemfibrozil—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.31e-05	0.000931	CbGpPWpGaD
Gemfibrozil—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	3.3e-05	0.000928	CbGpPWpGaD
Gemfibrozil—PPARA—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	3.27e-05	0.00092	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.26e-05	0.000919	CbGpPWpGaD
Gemfibrozil—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	3.26e-05	0.000917	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.24e-05	0.000911	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—GCLC—chronic obstructive pulmonary disease	3.2e-05	0.000901	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	3.18e-05	0.000896	CbGpPWpGaD
Gemfibrozil—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.18e-05	0.000896	CbGpPWpGaD
Gemfibrozil—SLCO1B1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	3.15e-05	0.000887	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.14e-05	0.000884	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	3.12e-05	0.000879	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	3.12e-05	0.000879	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.11e-05	0.000875	CbGpPWpGaD
Gemfibrozil—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.02e-05	0.000849	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3e-05	0.000845	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.98e-05	0.00084	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	2.98e-05	0.00084	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.98e-05	0.000838	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	2.97e-05	0.000837	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	2.97e-05	0.000837	CbGpPWpGaD
Gemfibrozil—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.96e-05	0.000833	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—CTGF—chronic obstructive pulmonary disease	2.92e-05	0.000822	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.92e-05	0.000822	CbGpPWpGaD
Gemfibrozil—PPARA—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.84e-05	0.000799	CbGpPWpGaD
Gemfibrozil—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	2.74e-05	0.000771	CbGpPWpGaD
Gemfibrozil—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.72e-05	0.000766	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	2.7e-05	0.00076	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.69e-05	0.000757	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.68e-05	0.000755	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.67e-05	0.000751	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	2.66e-05	0.000749	CbGpPWpGaD
Gemfibrozil—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.58e-05	0.000726	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—MMP9—chronic obstructive pulmonary disease	2.56e-05	0.000722	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.54e-05	0.000716	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.48e-05	0.000697	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	2.43e-05	0.000683	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	2.3e-05	0.000648	CbGpPWpGaD
Gemfibrozil—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.28e-05	0.000643	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.25e-05	0.000634	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.24e-05	0.000632	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.21e-05	0.000623	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.13e-05	0.000599	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	2.11e-05	0.000595	CbGpPWpGaD
Gemfibrozil—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.1e-05	0.000591	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	2.07e-05	0.000584	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—EGFR—chronic obstructive pulmonary disease	2.07e-05	0.000583	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.07e-05	0.000583	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.06e-05	0.000581	CbGpPWpGaD
Gemfibrozil—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.99e-05	0.00056	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.98e-05	0.000556	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—TNF—chronic obstructive pulmonary disease	1.97e-05	0.000556	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.96e-05	0.000552	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.96e-05	0.000552	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.96e-05	0.00055	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	1.92e-05	0.000541	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.9e-05	0.000534	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.83e-05	0.000514	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.81e-05	0.000508	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.79e-05	0.000503	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.76e-05	0.000496	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.75e-05	0.000492	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.73e-05	0.000487	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	1.72e-05	0.000483	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	1.71e-05	0.000482	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.68e-05	0.000474	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.65e-05	0.000464	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.61e-05	0.000453	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.6e-05	0.000451	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.6e-05	0.000451	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.59e-05	0.000449	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.59e-05	0.000449	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.59e-05	0.000448	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	1.56e-05	0.00044	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.52e-05	0.000427	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.48e-05	0.000416	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.45e-05	0.000409	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.42e-05	0.000401	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.37e-05	0.000387	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.34e-05	0.000376	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—ALB—chronic obstructive pulmonary disease	1.33e-05	0.000374	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—NOS3—chronic obstructive pulmonary disease	1.27e-05	0.000358	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.27e-05	0.000358	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.27e-05	0.000357	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.25e-05	0.000352	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.24e-05	0.00035	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.16e-05	0.000328	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.16e-05	0.000326	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.1e-05	0.000311	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.06e-05	0.000299	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.05e-05	0.000296	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	1.04e-05	0.000292	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.03e-05	0.00029	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	9.9e-06	0.000279	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	9.68e-06	0.000272	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.59e-06	0.00027	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	9.47e-06	0.000267	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.37e-06	0.000264	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	9.26e-06	0.000261	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.73e-06	0.000246	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.64e-06	0.000243	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.55e-06	0.000241	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	8.45e-06	0.000238	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	8.45e-06	0.000238	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.88e-06	0.000222	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.79e-06	0.000219	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	7.71e-06	0.000217	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—ALB—chronic obstructive pulmonary disease	7.5e-06	0.000211	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.3e-06	0.000206	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.28e-06	0.000205	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	7.22e-06	0.000203	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.18e-06	0.000202	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—NOS3—chronic obstructive pulmonary disease	7.17e-06	0.000202	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.1e-06	0.0002	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	6.73e-06	0.000189	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.69e-06	0.000188	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	6.59e-06	0.000185	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.5e-06	0.000183	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.41e-06	0.00018	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.34e-06	0.000178	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.97e-06	0.000168	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.92e-06	0.000167	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.84e-06	0.000164	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.66e-06	0.000159	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.64e-06	0.000159	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	5.57e-06	0.000157	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.44e-06	0.000153	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.16e-06	0.000145	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	5.08e-06	0.000143	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.06e-06	0.000142	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.99e-06	0.000141	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.68e-06	0.000132	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.65e-06	0.000131	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.41e-06	0.000124	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	4.31e-06	0.000121	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	4.12e-06	0.000116	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.91e-06	0.00011	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.85e-06	0.000108	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	3.85e-06	0.000108	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	3.68e-06	0.000104	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.59e-06	0.000101	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	3.51e-06	9.87e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.4e-06	9.58e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	3.36e-06	9.44e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	3e-06	8.44e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.87e-06	8.07e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.31e-06	6.51e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.21e-06	6.23e-05	CbGpPWpGaD
